Cetylpyridinium/Benzocaine Lozenges
Original notice title
Germany – Medical equipments, pharmaceuticals and personal care products – 1/DLII6/VM024 - CETYLPYRIDINIUM/BENZOCAIN LTBL
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
No estimated contract value disclosed; bidders cannot assess affordability or competitiveness.
Inconsistency between structured data (EU-funded) and XML notice (no EU funds). This affects compliance and funding con...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Oct 2026
- Supply of pharmaceutical lozenges (Cetylpyridinium/Benzocaine) in specified quantities.
Show full summary
Single lot tender for the supply of Cetylpyridinium/Benzocaine lozenges (medical product) for the German Federal Armed Forces. Open procedure. Estimated value not provided. Award criteria: quality 40% and price 60%. Deadline: 10 August 2026.
Risks
No estimated contract value disclosed; bidders cannot assess affordability or competitiveness.
Inconsistency between structured data (EU-funded) and XML notice (no EU funds). This affects compliance and funding con...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Delivery to Germany (place of performance not further specified; see price and product sheet).
- No variants allowed.
Administrative
- Electronic submission required via e-Vergabe platform.
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Bonn, DEU
Website
Identifier
t:0228886202143
Activity
Defence
Lots (1)
LOT-0000
Cetylpyridinium/Benzocaine Lozenges
Supply of 3,600,280 units of Cetylpyridinium/Benzocaine lozenges (100,080 + 2,700,000 + 800,100).
Location
Duration
Category
Award Criteria
Deadline
Award details
gem. Bewertungsmatrix
Additional CPV codes
Value note
Show original TED data
Original lot title
1/DLII6/VM024 - CETYLPYRIDINIUM/BENZOCAIN LTBL
Original TED description
100.080 EA CETYLPYRIDINIUM/BENZOCAIN LTBL 2.700.000 EA CETYLPYRIDINIUM/BENZOCAIN LTBL 800.100 EA CETYLPYRIDINIUM/BENZOCAIN LTBL
Procurement Details
- Publication date
- 08 Jul 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 473775-2026
Documents (2)
Similar tenders
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
No estimated contract value disclosed; bidders cannot assess affordability or competitiveness.
Inconsistency between structured data (EU-funded) and XML notice (no EU funds). This affects compliance and funding con...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications